CITIUS ONCOLOGY, INC. 8-K

What Happened
Citius Oncology, Inc. (CTOR) announced its results of operations for the full year ended fiscal 2025 in a press release dated December 23, 2025. The company filed a Form 8-K (Item 2.02) on the same date to furnish that press release and incorporate it by reference into the SEC filing.

Key Details

• Filing date: December 23, 2025; Item reported: 2.02 — Results of Operations and Financial Condition.
• The press release announcing full-year fiscal 2025 results is furnished as Exhibit 99.1 to the 8-K.
• The 8-K itself references the press release for the detailed financial information (the filing text does not restate the full financial metrics).

Why It Matters
This 8-K signals that Citius Oncology has publicly released its fiscal 2025 operating results—information investors use to evaluate recent revenue, earnings, cash position, and trends. Retail investors should read the December 23, 2025 press release (Exhibit 99.1) and monitor subsequent SEC filings (e.g., quarterly reports or the Form 10-K) for the full financial details and any management commentary or guidance.